Abl/c-kit/PDGFR抑制剂
英文名 | Imatinib Mesylate (STI571) | CAS号 | 220127-57-1 |
试剂别名 |
4-[(4-methyl-1-piperazinyl)methyl]-n-[4-methyl-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]phenyl]-benzamide monomethanesulfonate; 4-[(4-methylpiperazin-1-yl)methyl]-n-[4-methyl-3-[(4-pyridin-3-ylpyrimidin-2-yl)amino]phenyl]benzamide methanesulfonate; CGP-57148B; GLEEVEC; GLIVEC; IMATINIB METHANESULFONATE; STI-571; IMATINIB BASE(IMA-3); ImatinibMesylate/Gleevec; Imatinib Methanesulfonate, STI-571, CGP-57148B, Glivec; IMATINIB MESYLATE (IMATINIB METHANESULFONATE); alpha-IMATINIB MESYLATE; Imatinib mesylate(TINIBS ); 4-[(4-Methyl-1-piperazinyl)methyl]-N-[4-methyl-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]phenyl]-benzamide monomethanesulfonate; Imatinib mesylate / 4-[(4-Methylpiperazin-1-yl)methyl]-N-[4-methyl-3-[(4-pyridin-3-ylpyrimidin-2-yl)amino]phenyl]benzamide methanesulfonate
|
分子式 | C29H31N7O.CH4O3S |
产品编号 | APEA1805 | 分子量 | 589.72 |
MDL号 | MFCD04307699 |
产品名称: | Abl/c-kit/PDGFR抑制剂 |
英文名称: | Imatinib Mesylate (STI571) |
英文别名: | 4-[(4-methyl-1-piperazinyl)methyl]-n-[4-methyl-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]phenyl]-benzamide monomethanesulfonate; 4-[(4-methylpiperazin-1-yl)methyl]-n-[4-methyl-3-[(4-pyridin-3-ylpyrimidin-2-yl)amino]phenyl]benzamide methanesulfonate; CGP-57148B; GLEEVEC; GLIVEC; IMATINIB METHANESULFONATE; STI-571; IMATINIB BASE(IMA-3); ImatinibMesylate/Gleevec; Imatinib Methanesulfonate, STI-571, CGP-57148B, Glivec; IMATINIB MESYLATE (IMATINIB METHANESULFONATE); alpha-IMATINIB MESYLATE; Imatinib mesylate(TINIBS ); 4-[(4-Methyl-1-piperazinyl)methyl]-N-[4-methyl-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]phenyl]-benzamide monomethanesulfonate; Imatinib mesylate / 4-[(4-Methylpiperazin-1-yl)methyl]-N-[4-methyl-3-[(4-pyridin-3-ylpyrimidin-2-yl)amino]phenyl]benzamide methanesulfonate |
中文别名: | 甲磺酸伊马替尼 |
CAS No.: | 220127-57-1 |
分子式: | C29H31N7O.CH4O3S |
分子量: | 589.72 |
危险品级别: | |
HS符号: | |
危害声明: |